Skip to main content

Table 4 The development of non- alcoholic fatty liver disease across quartiles of energy-adjusted daily magnesium intake

From: Calcium to magnesium intake ratio and non-alcoholic fatty liver disease development: a case-control study

 

Energy-adjusted daily magnesium intake

Q1(n = 250)

Q2(n = 249)

P-value*

Q3(n = 250)

P-value*

Q4(n = 250)

P-value *

Cases/control

70/180

65/185

 

55/194

 

36/214

 

Range of energy-adjusted Mg

86.31 to 154.40

154.43 to 174.70

 

174.71 to 196.63

 

196.65 to 329.96

 

aModel 1

1 (Ref)

1.61

(0.57–2.34)

0.54

1.56

(0.78–3.49)

0.32

1.25

(0.61–5.56)

0.26

bModel 2

1 (Ref)

1.32

(0.75–3.32)

0.36

1.11

(0.65–4.31)

0.41

1.09

(0.74–6.32)

0.14

cModel 3

1 (Ref)

1.88

(0.53–4.53)

0.24

2.02

(0.48–6.21)

0.34

0.93

(0.81–5.70)

0.07

dModel 4

1 (Ref)

1.60

(0.43–2.34)

0.97

0.98

(0.71–3.61)

0.25

0.89

(1.25–4.78)

0.043

  1. Data are presented as odds ratio (95 %CI)
  2. *Logistic regression
  3. acrude model
  4. bAdjusted for age and gender
  5. cAdditionally adjusted for body mass index, alcohol consumption, smoking, diabetes and physical activity
  6. dAdditionally adjusted for energy, dietary fiber, carbohydrate, fat, and protein intakes
  7. The significance level: P < 0.05